Blackmores: Healthy sales, flat profit

A good sales result, but profit cracks starting to show?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What: Blackmores Limited (ASX: BKL) has today released its results for the nine months to 31st March 2012, and results show that vitamins and supplements have been good for this company. Sales came in at $186m, up 8.4 per cent compared to the previous corresponding period. Asian sales are up 19 per cent – held back by the high Australian dollar. In constant currency terms, sales were up 26 per cent.

Net profit after tax was down slightly at $20m, compared to $20.2m in the previous corresponding period.

However, it appears that Blackmores did not have a great 3rd quarter to the end of March 2012, with net profit sliding 4.4 per cent to $5.7m The decline in earnings before interest and taxes was an alarming -16.5%. An ongoing legal dispute with a building contractor, costing $1.2m so far this year has probably not helped.

The Company

Blackmores develops and markets a range of health products, including vitamins, herbal and mineral nutritional supplements. The company recently (July 2010) expanded into animal health, with distribution to over 800 veterinary clinics and 300 pet stores, as well as exports to New Zealand, North America and Korea.

The company also announced that it has progressed plans to launch in China beginning in the fourth quarter – in other words, between now and end of June 2012. The first shipment of Blackmores products is already on its way to China.

Blackmores also engaged in some unedifying spin, barely talking about profit on the first page of the earnings release and hiding a poor third-quarter result by focusing on the nine-month figures. Nothing dishonest of course – and Blackmores is far from Robinson Crusoe – but it's the type of corporate spin we deplore and investors could well do without.

So What: Blackmores have advised that profit for the full year to June 2012 will be in line with 2011's results, which was a net profit of $27.3m, earnings per share of $1.63 and $1.24 of fully franked dividends. On that basis, the company is trading on a forecast P/E of 17, with a prospective dividend yield of 4.5 per cent, fully franked.

Now What: Expanding sales into China and other Asian countries, is probably where Blackmores is going to garner much of the company's future growth, with competition in Australasia extremely tough.

Blackmores supplies products to both Coles — owned by Wesfarmers Limited (ASX: WES), and Woolworths Limited (ASX: WOW), and it's likely that both those companies are placing increasing pressure on Blackmores margins, as they take share from Australian Pharmaceutical Industries Ltd (ASX:API)  and Sigma Pharmaceutical Limited (ASX:SIP).

The company is one I'd like to own, but at current prices, it's just a tad too unhealthy for my bank account. I'll be watching from the sidelines for now.

If you're looking for income from your shares, look no further than "Secure Your Future with 3 Rock-Solid Dividend Stocks". In this free report, we've put together our best ideas for investors who are looking for solid companies with high dividends and good growth potential. Click here now to find out the names of our three favourite income ideas. But hurry – the report is free for only a limited time.

More reading

Motley Fool contributor Mike King owns shares in Woolworths. The Motley Fool's purpose is to educate, amuse and enrich investors. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. Click here to be enlightened by The Motley Fool's disclosure policy.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »